Watch: Trump signs executive order easing U.S. restrictions on psychedelic research
Summary
President Donald Trump signed an executive order to reduce U.S. restrictions on research involving psychedelic drugs. This includes drugs like ibogaine, which some countries use to treat post-traumatic stress disorder (PTSD).Key Facts
- President Trump signed the executive order on a Saturday.
- The order makes it easier to conduct research on psychedelic drugs in the U.S.
- Ibogaine is one of the psychedelics mentioned in the order.
- Ibogaine is used in some countries to help treat PTSD.
- The change aims to promote scientific study of these drugs.
- Psychedelic drugs can affect a person’s mind and perception.
- Past U.S. laws placed strict limits on such research.
- This move might lead to new treatments for mental health conditions.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
